Abstract:Acute graft-vs.-host disease (aGVHD) is a frequent complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), accounting for substantial morbidity and mortality associated with this treatment modality. The pathogenesis of aGVHD involves a complex cascade of humoral and cellular interactions in which donor T cells target HLA mismatched host tissues, causing tissue injury through secretion of pro-inflammatory cytokines and induction of direct cytotoxicity. Toll-like receptors (TLRs) are key components of the innate immune system that recognize endogenous danger-associated molecular patterns (DAMPs) and exogenous pathogen-associated molecular patterns (PAMPs). Patients receiving conditioning chemotherapy and/or whole-body irradiation prior to all-HSCT are prone to gastrointestinal damage and translocation of microbiota across compromised intestinal epithelium, resulting in release of PAMPs and DAMPs. These "danger signals" play critical roles in disease pathogenesis by both initiating and propagating aGVHD through dendritic cell maturation and alloreactive T cell responses. There are 10-15 TLRs identified in mammalian species, a subset of which recognize single-stranded RNA (ssRNA) and serve as a key component of viral immunity. Recently, ssRNAs other than those of viral origin have been investigated as potential ligands of TLRs. MicroRNAs (miRs) are short (19-24 nt) non-coding RNAs that play critical roles in a variety of diseases. While traditionally miRs post-translationally modulate gene expression, non-canonical functions such as regulating TLR stimulation by acting as TLR ligands have been described. Here, we review the role of TLRs in aGVHD pathogenesis, the function of miRs in TLR stimulation, and the recent literature describing miRs as TLR ligands in aGVHD.

Toll-like receptors and graft rejection.

Role of IL-18 in Transplant Biology

The Role of Toll-Like Receptors 2 and 4 in Acute Allograft Rejection after Liver Transplantation

Activation of immune signals during organ transplantation

Innate allorecognition by monocytic cells and its role in graft rejection

Toll‐like Receptors and Immune Regulation: Their Direct and Indirect Modulation on Regulatory CD4+ CD25+ T Cells

Antagonistic Effect of Toll-Like Receptor Signaling and Bacterial Infections on Transplantation Tolerance

Innate immune modulation in transplantation: mechanisms, challenges, and opportunities

CD4+ T‐cell Subsets in Transplantation

Innate and Adaptive Immune Responses in Intestinal Transplant Rejection: Through the Lens of Inflammatory Bowel and Intestinal Graft-Versus-Host Diseases

Innate immunity: Trained immunity and innate allorecognition against the allograft

Innate Immune Cells in Transplantation

Advance on Toll-like Receptors

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

The Role of Pattern-Recognition Receptors in Graft-Versus-Host Disease and Graft-Versus-Leukemia after Allogeneic Stem Cell Transplantation

TH1 Immune Responses to Fully MHC Mismatched Allografts are Diminished in the Absence of MyD88, a Toll-Like Receptor Signal Adaptor Protein

Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease

Endogenous toll-like receptor ligands and their biological significance.

Toll-like Receptor and Tumor Immunity

Toll-like receptors in inflammation, infection and cancer

TLR Signals Promote IL-6/IL-17-dependent Transplant Rejection.